Day One Biopharmaceuticals Inc (DAWN)
13.72
+0.38
(+2.85%)
USD |
NASDAQ |
Nov 22, 16:00
15.14
+1.42
(+10.35%)
After-Hours: 20:00
Day One Biopharmaceuticals Total Liabilities (Quarterly): 45.34M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 45.34M |
June 30, 2024 | 93.71M |
March 31, 2024 | 29.84M |
December 31, 2023 | 29.51M |
September 30, 2023 | 24.55M |
June 30, 2023 | 24.70M |
March 31, 2023 | 23.15M |
December 31, 2022 | 17.02M |
Date | Value |
---|---|
September 30, 2022 | 18.78M |
June 30, 2022 | 13.42M |
March 31, 2022 | 8.176M |
December 31, 2021 | 8.673M |
September 30, 2021 | 6.111M |
June 30, 2021 | 4.774M |
March 31, 2021 | 224.95M |
December 31, 2020 | 94.16M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.774M
Minimum
Jun 2021
224.95M
Maximum
Mar 2021
41.68M
Average
23.85M
Median
Total Liabilities (Quarterly) Benchmarks
Perspective Therapeutics Inc | 62.68M |
Electromed Inc | 7.427M |
Xtant Medical Holdings Inc | 53.16M |
Myomo Inc | 7.020M |
Catheter Precision Inc | 13.92M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 600.81M |
Shareholders Equity (Quarterly) | 555.46M |
Current Ratio | 14.62 |